Atara Biotherapeutics Inc
ATRA
Market Cap$85.08M
Close$
$2.35
240.9% upside
Current Fair Value
240.9% upsideUndervalued by 240.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $85.08 Million |
|---|---|
| Enterprise Value | $79.05 Million |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-2.61 |
| Beta | 3.05 |
| Outstanding Shares | 119,359,230 |
| Avg 30 Day Volume | 1,252,562 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -0.31 |
|---|---|
| PEG | 1.63 |
| Price to Sales | - |
| Price to Book Ratio | -0.69 |
| Enterprise Value to Revenue | 9.22 |
| Enterprise Value to EBIT | -0.29 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.58 |
| Debt to Equity | -0.46 |
Revenue Sources
No data
ESG Score
No data
About Atara Biotherapeutics Inc
CEO: Pascal Touchon